Official Title: Early Identification of Cognitive Side-Effects of Immunotherapy
Status: RECRUITING
Status Verified Date: 2024-05
Last Known Status: None
Delayed Posting: No
If Stopped, Why?: Not Stopped
Has Expanded Access: False
If Expanded Access, NCT#: N/A
Has Expanded Access, NCT# Status: N/A
Acronym: None
Brief Summary: This clinical trial evaluates the use of a tool kit Stress Affect Language and Speech Analysis SALSA for early identification of cognitive side effects of immunotherapy compared to the standard of care assessment
Detailed Description: PRIMARY OBJECTIVES
I To investigate the use of a toolkit for automated administration and scoring of cognitive tests Stress Language and Speech Analysis or SALSA in adult cancer patients who are treated with commercial chimeric antigen receptor T cell therapy CAR-T products at University of Minnesota and are at risk of developing immune effector cell-associated neurotoxicity syndrome ICANS
OUTLINE This is an observational study
Patients complete SALSA assessment and ICE assessments on study Patients also have their medical records reviewed on study